Toggle navigation
About
Abstract
Editorial Board
Publication Schedule
Subscription & Newsletter
Contact
Issue
24-1/2
Table of Contents
Editors Selection
Glaucoma Dialogue
Glaucoma Opinion
Abstracts
Abstracts
Abstracted Journals
Classification List
Index of Authors
Search
Home
Abstracts
Index of Authors
Author #40923
advertisement
Yoshida M
18
Showing records 1 to 18 |
Display all abstracts from
Yoshida M
109750
The Relationship Between Kiritsu-Meijin-Derived Autonomic Function Parameters and Visual-Field Defects in Eyes with Open-Angle Glaucoma
Yamada Y
Current Eye Research
2023; 48: 1006-1013
109891
The GPR84 molecule is a mediator of a subpopulation of retinal microglia that promote TNF/IL-1α expression via the rho-ROCK pathway after optic nerve injury
Sato K
GLIA
2023; 71: 2609-2622
109753
DPP-4 Inhibitors Attenuate Fibrosis After Glaucoma Filtering Surgery by Suppressing the TGF-β/Smad Signaling Pathway
Yoshida M
Investigative Ophthalmology and Visual Science
2023; 64: 2
109750
The Relationship Between Kiritsu-Meijin-Derived Autonomic Function Parameters and Visual-Field Defects in Eyes with Open-Angle Glaucoma
Kiyota N
Current Eye Research
2023; 48: 1006-1013
109753
DPP-4 Inhibitors Attenuate Fibrosis After Glaucoma Filtering Surgery by Suppressing the TGF-β/Smad Signaling Pathway
Kokubun T
Investigative Ophthalmology and Visual Science
2023; 64: 2
109891
The GPR84 molecule is a mediator of a subpopulation of retinal microglia that promote TNF/IL-1α expression via the rho-ROCK pathway after optic nerve injury
Ohno-Oishi M
GLIA
2023; 71: 2609-2622
109753
DPP-4 Inhibitors Attenuate Fibrosis After Glaucoma Filtering Surgery by Suppressing the TGF-β/Smad Signaling Pathway
Sato K
Investigative Ophthalmology and Visual Science
2023; 64: 2
109750
The Relationship Between Kiritsu-Meijin-Derived Autonomic Function Parameters and Visual-Field Defects in Eyes with Open-Angle Glaucoma
Yoshida M
Current Eye Research
2023; 48: 1006-1013
109891
The GPR84 molecule is a mediator of a subpopulation of retinal microglia that promote TNF/IL-1α expression via the rho-ROCK pathway after optic nerve injury
Yoshida M; Sato T
GLIA
2023; 71: 2609-2622
109753
DPP-4 Inhibitors Attenuate Fibrosis After Glaucoma Filtering Surgery by Suppressing the TGF-β/Smad Signaling Pathway
Tsuda S
Investigative Ophthalmology and Visual Science
2023; 64: 2
109750
The Relationship Between Kiritsu-Meijin-Derived Autonomic Function Parameters and Visual-Field Defects in Eyes with Open-Angle Glaucoma
Omodaka K
Current Eye Research
2023; 48: 1006-1013
109753
DPP-4 Inhibitors Attenuate Fibrosis After Glaucoma Filtering Surgery by Suppressing the TGF-β/Smad Signaling Pathway
Yokoyama Y
Investigative Ophthalmology and Visual Science
2023; 64: 2
109891
The GPR84 molecule is a mediator of a subpopulation of retinal microglia that promote TNF/IL-1α expression via the rho-ROCK pathway after optic nerve injury
Aizawa T
GLIA
2023; 71: 2609-2622
109750
The Relationship Between Kiritsu-Meijin-Derived Autonomic Function Parameters and Visual-Field Defects in Eyes with Open-Angle Glaucoma
Nakazawa T
Current Eye Research
2023; 48: 1006-1013
109753
DPP-4 Inhibitors Attenuate Fibrosis After Glaucoma Filtering Surgery by Suppressing the TGF-β/Smad Signaling Pathway
Himori N
Investigative Ophthalmology and Visual Science
2023; 64: 2
109891
The GPR84 molecule is a mediator of a subpopulation of retinal microglia that promote TNF/IL-1α expression via the rho-ROCK pathway after optic nerve injury
Sasaki Y; Maekawa S
GLIA
2023; 71: 2609-2622
109753
DPP-4 Inhibitors Attenuate Fibrosis After Glaucoma Filtering Surgery by Suppressing the TGF-β/Smad Signaling Pathway
Nakazawa T
Investigative Ophthalmology and Visual Science
2023; 64: 2
109891
The GPR84 molecule is a mediator of a subpopulation of retinal microglia that promote TNF/IL-1α expression via the rho-ROCK pathway after optic nerve injury
Ishikawa M; Omodaka K; Kawano C; Ohue-Kitano R; Kimura I; Nakazawa T
GLIA
2023; 71: 2609-2622
Issue
24-1/2
Table of Contents
Editor's Selection
PDF
EPUB
Change Issue
25-1
24-4
24-3
24-1/2
23-4
23-3
23-2
23-1
22-4
22-3
22-2
22-1
21-4
21-3
21-2
21-1
20-4
20-3
20-2
20-1
19-4
19-3
19-2
19-1
18-4
18-3
18-2
18-1
17-4
17-3
17-2
17-1
16-4
16-3
16-2
16-1
15-4
15-3
15-2
15-1
14-4
14-3
14-2
14-1
13-4
13-3
13-2
13-1
12-4
12-3
12-2
12-1
11-4
11-3
11-2
11-1
10-4
10-3
10-2
10-1
9-4
9-3
9-2
9-1
8-4
8-3
8-2
8-1
7-3
7-2
7-1
6-3
6-2
6-1
5-3
5-2
5-1
4-3
4-2
4-1
3-3
3-2
3-1
2-3
2-2
2-1
1-3
1-2
1-1
advertisement